Cleared Traditional

K030920 - POGS 33

K030920 is an FDA 510(k) clearance for POGS 33, manufactured by On Site Gas Systems, Inc.. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 352-day FDA review.

K030920 · On Site Gas Systems, Inc. · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2004
Decision
352d
Days
Class 2
Risk

K030920 is an FDA 510(k) clearance for the POGS 33. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by On Site Gas Systems, Inc. (Newington,, US). The FDA issued a Cleared decision on March 10, 2004 after a review of 352 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K030920

510(k) Number K030920 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 2003
Decision Date March 10, 2004
Days to Decision 352 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
212d slower than avg
Panel avg: 140d · This submission: 352d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 224
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K030920.
MOBILE OXYGEN STORAGE TANK (MOST)
K040738 · Pacific Consolidated Industries Llp · Apr 2004
MARK 5 NUVO OCSI (M5C5), MODELS 505 AND 905
K040892 · Nidek Medical Products, Inc. · Apr 2004
MARK 5 NUVO (M5C5)
K032509 · Nidek Medical Products, Inc. · Mar 2004
TRAVELSOME STANDARD
K030233 · Sim Italia S.R.L. · Apr 2003
PORTABLE THERAPEUTIC OXYGEN CONCENTRATION SYSTEM (PTOCS)
K022684 · Essex Cryogenics of Missouri, Inc. · Sep 2002
VENTURE HOMEFILL II WITH OXYGEN CONSERVER
K021685 · Invacare Corp. · Jul 2002